Introduction
Angiotensin II (AT h) has a large number of effects with considerable biological significance.
These include actions on membrane function, protein synthesis, cell growth, hormone synthesis, maintenance of salt and volume homeostasis, blood pressure control, stimulation of dipsogenic behavior (thirst and drinking), and stimulation of release of pituitary hormones (Ganten et al. 1984; Unger et al. 1988; Chan et al. 1991) . Over the past few years it has been demonstrated that AT II markedly alters some types of behavior: seizure susceptibility, exploratory behavior and behavior after aversive stimulation (active and passive avoidance) (Georgiev, 1990) . In producing its behavioral effects, AT II interacts with 1) Visiting professor on leave from the Department of Experimental Pharmacology , Institute dopamine, NA, GABA and cholinergic neurotransmission (Georgiev et al. 1987 (Georgiev et al. , 1990 Georgiev and Kambourova, 1989; Yonkov and Georgiev, 1990) . AT II can also modulate defensive burying behavioral responses in rats (Tsuda et al. 1992 ). Many of the stressful stimuli including immobilization stress that activate the hypothalamopituitaryadrenocortical system also increase plasma renin activity and AT II acting on AT II receptors (Ganong and Barbieri, 1982; Gehlert et al. 1986; Schonenberg et al. 1987 ). There is a high concentration of AT II binding sites both in the hypothalamic paraventricular nucleus (Gehlert et al. 1986 ), which is the site of corticotropin-releasing factor (CRF) production, and in the anterior pituitary lobe, which is the site of ACTH (adrenocorticotropic  hormone) production. Both CRF and ACTH release have been reported to be enhanced by AT II (Schonenberg et al. 1987) . By measuring levels of NA and its major metabolite in the rat brain, MHPG-S04, it has been demonstrated that a variety of stressful stimuli markedly increase NA release in rat brain regions and that these increases have different characteristics related to the brain regions and/or to the nature of the stressor (Nakagawa et al. 1981; Tanaka et al. 1982a Tanaka et al. , b, 1983 . Of the stressors examined, immobilization stress has been documented to induce marked increases in NA release in extended brain regions (Tanaka et al. 1982a (Tanaka et al. , b, 1983 Ida et al. 1984 Ida et al. , 1985 .
Based on the established interaction of AT II with noradrenergic neuroeffector transmission (Story and Ziogas, 1987) , the present study was undertaken to investigate the effects of AT II, injected ICV, on levels of NA and its major metabolite, MHPG-S04, in discrete brain regions of rats, in non-stress and stress situations. The animals were allowed to recover for 5 days.
The effects of acutely-injected AT II on regional NA and MHPG-S04 levels in non-stressed and stressed rats were investigated.
Rats in the non-stressed groups (8 rats in each group) were injected with either AT II at a dose of 1 or 10 pg or saline, 65 min before sacrifice. The remaining three stress groups received identical injections, however, 5 min after the injections these animals were exposed to immobilization stress for 1 hr. Levels of NA and MHPG-SO 4, the major metabolite of rat brain NA which is indicative of brain NA release, were determined simultaneously by a f luorometric method (Kohno et al. 1979) . Several previous reports indicate that the changes in metabolite levels are more sensitive than NA levels (Tanaka et al. 1982a (Tanaka et al. , b, 1983 
Results
The effects of acute administration of AT II on levels of NA and MHPG -SO 4 i n discrete brain regions in non-stressed and stressed rats are summarized in Figs 1 , 2 and Table 1 . AT II administered at a dose of 1p to non-stressed rats significantly decreased MHPG-SO 4 levels in the thalamus and tended to increase them in the LC region. AT II administered at a dose of 10 ,ag significantly elevated the metabolite levels in the midbrain and cerebral cortex and tended to increase them in the thalamus ( Fig. 1 ). AT II administered at either dose did not affect MHPG-SO 4 levels in the other brain regions of nonstressed rats (Fig. 1) .
One hour of immobilization stress significantly increased the MHPG-SO 4 levels in all brain regions examined ( Fig. 1 ), and this was accompanied by significant reductions of NA levels in the midbrain and amygdala, and a tendency toward decreased levels in the hypothalamus, thalamus and hippocampus ( Fig. 2) . Pretreatment with AT II either at 1 or 10 ,cg did not significantly affect the increases in metabolite levels induced by stress in any brain region but tended to reduce them in the hypothalamus, thalamus and amygdala (at 1 1ag) (Fig. 1) . Pretreatment with AT II at 1 1ag significantly reduced NA levels in the thalamus and midbrain induced by stress (Fig. 2) . The amine/ metabolite ratios ranged from 7. 12 to 1.56 in non-stressed rats (Table 1 ). The hypothalamus exhibited the highest ratio, 
Discussion
One hour immobilization stress induced significant increases in MHPG-SO 4 levels in all brain regions examined; and in some brain regions, these increases were accompanied by significant reductions in NA levels. These findings indicate that immobilization stress increases NA release in these brain regions, as previously reported (Tanaka et al. 1982a (Tanaka et al. , b 1983 (Tanaka et al. , 1988 Ida et al. 1984) .
AT II attenuates stress-induced increases in MHPG-SO4 in the hypothalamus, thalamus and amygdala. However, in non-stressed rats, AT significantly increased MHPG -SO 4 levels in two (midbrain and cerebral cortex) of the seven brain regions examined. This finding suggests that AT II increases NA release in 'a restricted number of brain regions. Moreover, increases in NA release induced by AT II are likely to be similar to those seen in stress, since increases in MHPG-S04 levels induced by AT II in non-stressed rats were almost as marked as those caused by stress and were accompanied by reductions in NA levels in several brain regions (thalamus, midbrain and amygdala), that were also affected by stress.
This suggests that AT II enhances NA release in some brain regions under normal conditions.
Various stressors including immobilization (Nakagawa et al. 1981; Tsuda et al. 1989 Tsuda et al. , 1990 Tanaka et al. 1990 ) have been reported to cause increases in NA release in regions of the rat brain. It has been generally accepted that stress increases NA release in many brain regions of rodents.
These stress-induced increases in NA release were closely related to the negative emotional changes of the animals exposed to stress, i. e., fear and/ or anxiety (Tanaka et al. 1982b (Tanaka et al. , 1983 (Tanaka et al. , 1986 (Tanaka et al. , 1990 (Tanaka et al. 1983 ) and opioid peptides (Tanaka et al. 1990 ), which possess stressreducing properties. Increases in NA release induced by the acute administration of AT H in normal conditions in the midbrain and cerebral cortex and to some extent in the amygdala and LC region are similar to those induced by stressors with differences in degrees. However, the mechanism by which AT H increases NA release is still under investigation. In conscious rats, AT Il administered ICY, significantly increased NA release in the paraventricular nucleus of the hypothalamus, as shown by microdialysis coupled to HPLC with electrochemical detection (Stadler et al. 1992 ). This effect was abolished by an AT 1 receptor nonpeptide antagonist, DuP 753, demonstrating that it was mediated by an AT 1 receptor (Stadler et al. 1992 ). The effect of AT 11 on NA release is specific for this region, because 1 mm caudal to this nucleus, AT II did not affect the release of NA from this area. Thus the AT IIinduced NA release is confined to the specific hypothalamic nuclei involved in the actions of the peptide. Furthermore, Huang et al. (1987) presented evidence that AT 11 (3-100 nM) facilitated the potassium-evoked release of 3H-NA from slices of the rat parietal cortex in a concentration-dependent manner, but did not significantly alter the release of 3H-NA evoked in a similar manner from LC slices. This difference in NA release from the two brain structures is difficult to explain, as it is known that the LC, which comprises approximately 45% of all noradrenergic cell bodies in the brain, contains a high density of AT 11 binding sites, and the cerebral cortex has a low density of AT 11 binding sites (Gehlert et al. 1986 ). Most known effects of AT 11 are elicited through binding of the peptide to plasma membrane AT II receptors which mediate inhibition of adenylate cyclase, stimulation of phosphoinositide hydrolysis as well as mobilization of intracellular Ca2+ through interaction with G-proteins.
AT1 subtype receptors interact with G-proteins and AT 2 subtype receptors do not appear to be able to interact with G-2 proteins (Bottari et al. 1991) .
To produce the effects on NA release the primary event may be the binding of ICY administered AT II to AT II receptors (Gehlert et al. 1986) or to type 1 or type 2 AT 11 receptors in specialized regions of the brain (Unger et al. 1988 ). Specifically, it was reported that type 1 AT II receptors play a role in stress (Wamsley et al. 1990; Tsutsumi and Saavedra, 1991) . Stress increases the density of AT II binding sites in the subf ornical organ and the parvocellular paraventricular nucleus, which has a key role in the central regulation of the stress response, and is also involved in the regulation of peripheral sympathetic activity (Castren and Saavedra, 1988) . Many findings support the participation of NA in behavioral processes (Tanaka et al. 1977) . The increase of NA turnover by AT II in some rat brain regions might be a facilitating effect of the peptide on the retention of avoidance behavior (Yonkov et al. 1986 (Yonkov et al. , 1989 Georgiev, 1990; Yonkov and Georgiev, 1990) Stress may induce changes in the ability of AT II receptors to influence NA release at the presynaptic level, in particular, at presynaptic a2-receptors (autoreceptors) which usually inhibit NA release. This would change the interactions between AT II receptors (both subtypes) and a 2 -autoreceptors, i, e., he ability of AT II to presynaptically control NA release. AT 11-induced changes in NA release in the brain regions examined might also be realized indirectly through influences on ACTH and vasopressin release. In conclusion, the present study has provided a number of lines of evidence that AT II increases NA release in a restricted number of brain regions in nonstressed rats and attenuates increases in NA release induced by immobilization stress i n brain regions, such as the hypothalamus, amygdala and thalamus. These attenuating effects on stress-induced increases in brain NA release induced by AT II administered ICY may be, in part, related to a reduction of fear and/or anxiety in the animals exposed to stress. BOTTARI, S. P., TAYLOR, V., KING, I. N., BOGDAL, Y., WHITERBREAD, S. et al. (1991 ROGERS, J. and HENDERSON, G. (1987) .
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